Christine Brideau is a Vice President of In Vitro Pharmacology, Deerfield Discovery and Development, and joined the Firm in 2019. Prior to Deerfield, Ms. Brideau was Vice President of In Vitro Pharmacology at WuXi AppTec and led the development of WuXi’s US-based in vitro biology unit in New Jersey. Before WuXi, Ms. Brideau spent 24 years at Merck, where she most recently served as Executive Director of In Vitro Pharmacology and supported multiple drug discovery projects from hit-to-lead to clinical candidate. She is the co-author of more than 40 peer-reviewed publications in the areas of pharmacology, assay development, screening day analysis, automation and compound management. Ms. Brideau is currently an editorial board member of SLAS Discovery and has served as a reviewer for the NIH Molecular Libraries Program study section.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.Read More
Supporting companies across the healthcare ecosystem with flexible funding models…Read More
FeaturedIllumina and Deerfield Management partner to accelerate drug development PE Hub: Every disease is a finite puzzle Deerfield Management Announces XSeed Award Winners Break Into the Boardroom Fills Over 50 Healthcare Board Seats With Women Leaders
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.Read More
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.Read More Meet the Foundation Team
Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.Read More Meet the Cure Team Join the Cure Email List
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.Cure Symposium Calendar